149 related articles for article (PubMed ID: 18547912)
1. Transit dose contributions to intracavitary and interstitial PDR brachytherapy treatments.
Menon GV; Carlone MC; Sloboda RS
Phys Med Biol; 2008 Jul; 53(13):3447-62. PubMed ID: 18547912
[TBL] [Abstract][Full Text] [Related]
2. Safety aspects of pulsed dose rate brachytherapy: analysis of errors in 1,300 treatment sessions.
Koedooder K; van Wieringen N; van der Grient HN; van Herten YR; Pieters BR; Blank LE
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):953-60. PubMed ID: 18262105
[TBL] [Abstract][Full Text] [Related]
3. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
[TBL] [Abstract][Full Text] [Related]
4. [Pulse dose rate curietherapy].
Mazeron JJ; Boisserie G; Baillet F
Bull Cancer Radiother; 1995; 82(3):332-5. PubMed ID: 8554884
[TBL] [Abstract][Full Text] [Related]
5. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
6. The contribution from transit dose for (192)Ir HDR brachytherapy treatments.
Fonseca GP; Landry G; Reniers B; Hoffmann A; Rubo RA; Antunes PC; Yoriyaz H; Verhaegen F
Phys Med Biol; 2014 Apr; 59(7):1831-44. PubMed ID: 24625517
[TBL] [Abstract][Full Text] [Related]
7. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids.
Mourtada F; Gifford KA; Berner PA; Horton JL; Price MJ; Lawyer AA; Eifel PJ
Med Dosim; 2007; 32(3):181-7. PubMed ID: 17707197
[TBL] [Abstract][Full Text] [Related]
8. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
9. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit.
Palmer A; Mzenda B
Phys Med Biol; 2009 Dec; 54(24):7417-34. PubMed ID: 19934487
[TBL] [Abstract][Full Text] [Related]
10. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
[TBL] [Abstract][Full Text] [Related]
11. [Pulsed dose rate brachytherapy: a method description and review of clinical application].
Skowronek J; Piotrowski T
Przegl Lek; 2002; 59(1):31-6. PubMed ID: 12108044
[TBL] [Abstract][Full Text] [Related]
12. A linear source table to determine the treatment times for cylindrical applicators used in high-dose rate brachytherapy.
Sha RL; Reddy PY; Sahoo N
Brachytherapy; 2011; 10(3):249-52. PubMed ID: 20933480
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent screen for high-dose-rate (HDR) brachytherapy quality assurance.
Lightstone AW
Med Dosim; 2005; 30(3):143-4. PubMed ID: 16112464
[TBL] [Abstract][Full Text] [Related]
14. Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy.
Das RK; Bradley KA; Nelson IA; Patel R; Thomadsen BR
Brachytherapy; 2006; 5(1):56-60. PubMed ID: 16563998
[TBL] [Abstract][Full Text] [Related]
15. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
[TBL] [Abstract][Full Text] [Related]
16. Measurement of transit time of a remote after-loading high dose rate brachytherapy source.
Sahoo N
Med Phys; 2001 Aug; 28(8):1786-90. PubMed ID: 11548950
[TBL] [Abstract][Full Text] [Related]
17. Pulsed-dose-rate brachytherapy: design of convenient (daytime-only) schedules.
Brenner DJ; Schiff PB; Huang Y; Hall EJ
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):809-15. PubMed ID: 9369127
[TBL] [Abstract][Full Text] [Related]
18. [A proposal for dosage and volume specification and documentation in HDR brachytherapy].
Krieger H; Baltas D; Kneschaurek P
Strahlenther Onkol; 1996 Oct; 172(10):527-42. PubMed ID: 8966670
[TBL] [Abstract][Full Text] [Related]
19. Independent assessment of source transit time for the BEBIG SagiNova® cobalt-60 high dose rate brachytherapy afterloader.
Kanani A; Karbasi S; Mosleh-Shirazi MA
Australas Phys Eng Sci Med; 2019 Dec; 42(4):913-919. PubMed ID: 31452058
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of a digital simulator for rapid setup verification in high dose rate brachytherapy.
Zwicker RD; Atari NA; Kavanagh BD; Gieschen HL; Arnfield MR; Khandelwal SR; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):931-6. PubMed ID: 7591905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
